羟基氯喹
医学
甲氨蝶呤
银屑病
皮肤病科
脓疱性银屑病
皮肤损伤
关节炎
外科
内科学
疾病
2019年冠状病毒病(COVID-19)
传染病(医学专业)
作者
John E. Vine,Sharon R. Hymes,Noranna B. Warner,Philip R. Cohen
标识
DOI:10.1111/j.1346-8138.1996.tb04031.x
摘要
Abstract A variety of pharmacologic agents have been known to induce pustular psoriasis. We describe a patient with a positive personal and family history of psoriasis who developed an extensive annular pustular eruption 3 weeks after starting hydroxychloroquine (Plaquenil) for arthritis. The drug was discontinued, and she received 3 weeks of systemic and topical corticosteroids; in spite of the therapeutic intervention, showers of new lesions appeared daily, and progressed to involve 75% of the body. The development of new lesions stopped, and the older lesions began to clear after one dose of 7.5 mg of methotrexate. Subsequently, methotrexate therapy was stopped because of mild transaminase elevation; the pustular lesions then flared. New lesions stopped appearing after four doses of weekly methotrexate. The patient remains clear of lesions 6 months later.
科研通智能强力驱动
Strongly Powered by AbleSci AI